SCHEMBL7649262

SCHEMBL7649262

CCC(CCO)c1ccc(-c2cc(CCc3ccc(CO)c(CO)c3)sc2C)c(C)c1

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
VDR P11473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7648312 0.86 VDR (0.38) VDR
SCHEMBL7615200 0.85 VDR (0.52) VDR
SCHEMBL7649265 0.82 VDR (0.38) VDR
SCHEMBL7647798 0.81 VDR (0.39) VDR
SCHEMBL6565142 0.77 VDR (0.61) VDR
SCHEMBL7606174 0.75 VDR (0.53) VDR
SCHEMBL7607761 0.74 VDR (0.45) VDR
SCHEMBL7610503 0.73 VDR (0.42) VDR
SCHEMBL7606748 0.73 VDR (0.35) VDR
SCHEMBL7608506 0.71 LTB4R (0.34) VDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235777-A2 VITAMIN D ANALOGUES Galderma Research & Development, S.N.C. (FR) 2002-09-04 EP disclosed
WO-2001038303-A2 VITAMIN D ANALOGUES GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2001-05-31 WO disclosed